StockData
Elutia Inc. logo

Elutia Inc. (ELUT) stock

ELUTNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 9/3011% below fair value
$0.81−0.02 (-2.41%)

Close on Nov 19, 2026Market cap $35.87MP/E –Yield –

Elutia free cash flow

Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.

Elutia's free cash flow for the twelve months ending Jun 30, 2026 was -$46.03M. For fiscal 2025 it was -$46.69M. The highest annual figure on record is -$7.80M in fiscal 2019.

Annual free cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$46.69M–
FY2024Dec 31, 2024-$23.31M–
FY2023Dec 31, 2023-$22.11M–
FY2022Dec 31, 2022-$21.97M–
FY2021Dec 31, 2021-$15.82M–
FY2020Dec 31, 2020-$14.27M–
FY2019Dec 31, 2019-$7.80M–

Quarterly free cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$8.55M–
Q1 FY2026Mar 31, 2026-$8.29M–
Q4 FY2025Dec 31, 2025-$25.67M–
Q3 FY2025Sep 30, 2025-$3.52M–
Q2 FY2025Jun 30, 2025-$8.34M–
Q1 FY2025Mar 31, 2025-$9.16M–
Q4 FY2024Dec 31, 2024-$12.35M–
Q3 FY2024Sep 30, 2024-$3.97M–
Q2 FY2024Jun 30, 2024-$4.33M–
Q1 FY2024Mar 31, 2024-$2.66M–
Q4 FY2023Dec 31, 2023-$9.10M–
Q3 FY2023Sep 30, 2023-$5.19M–
Q2 FY2023Jun 30, 2023-$2.47M–
Q1 FY2023Mar 31, 2023-$5.35M–
Q2 FY2022Jun 30, 2022-$10.96M–
Q1 FY2022Mar 31, 2022-$7.38M–
Q4 FY2021Dec 31, 2021-$6.41M–
Q3 FY2021Sep 30, 2021-$3.20M–
Q2 FY2021Jun 30, 2021-$903.00K–
Q1 FY2021Mar 31, 2021-$5.31M–
Q4 FY2020Dec 31, 2020-$5.48M–
Q3 FY2020Sep 30, 2020-$1.67M–
Q2 FY2020Jun 30, 2020-$4.02M–
Q1 FY2020Mar 31, 2020-$3.10M–
Q4 FY2019Dec 31, 2019-$2.73M–

More Elutia figures

See a number that looks wrong?